A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3396454)

Published in J Clin Aesthet Dermatol on July 01, 2012

Authors

James Q Del Rosso, Leon Kircik

Articles cited by this

Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol (2009) 1.94

Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol (2004) 1.81

Guidelines for management of atopic dermatitis. J Dermatol (2009) 1.54

Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol (2005) 1.20

Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol (2004) 1.20

Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs (1988) 1.18

Guidelines for the management of contact dermatitis: an update. Br J Dermatol (2009) 0.98

Glucocorticoid receptor binding: a biphasic dependence on molecular size as revealed by the bilinear LinBiExp model. Steroids (2007) 0.94

The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol (2006) 0.89

Therapeutic update on seborrheic dermatitis. Skin Therapy Lett (2010) 0.84

Percutaneous absorption of steroids: determination of in vitro permeability and tissue reservoir characteristics in human skin layers. Skin Pharmacol Physiol (2006) 0.84

Topical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development--a process of "planned serendipity". J Pharm Sci (2008) 0.82

Advised best practice for the use of emollients in eczema and other dry skin conditions. J Dermatolog Treat (2002) 0.82

Articles by these authors

Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne. J Drugs Dermatol (2008) 1.45

Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol (2006) 1.43

The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol (2011) 1.40

Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. N Engl J Med (2015) 1.20

Dermatofibrosarcoma protuberans: a case report and review of the literature. J Clin Aesthet Dermatol (2008) 1.16

Atypical mycobacterial cutaneous infections. Dermatol Clin (2009) 1.15

Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol (2013) 1.08

Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol (2011) 1.07

Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis (2007) 1.03

Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol (2009) 0.98

Anti-inflammatory activity of tetracyclines. Dermatol Clin (2007) 0.98

Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol (2013) 0.98

Calciphylaxis: a review. J Clin Aesthet Dermatol (2008) 0.98

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol (2014) 0.96

Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol (2010) 0.92

Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol (2009) 0.92

Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol (2009) 0.92

Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. J Clin Aesthet Dermatol (2012) 0.92

Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin. J Drugs Dermatol (2012) 0.91

Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin (2009) 0.91

5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg (2007) 0.91

Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? J Clin Aesthet Dermatol (2013) 0.90

A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol (2009) 0.89

Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations. Biopsychosoc Med (2011) 0.87

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis. J Am Acad Dermatol (2013) 0.87

Skin cancer in asians: part 2: melanoma. J Clin Aesthet Dermatol (2009) 0.87

Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. J Drugs Dermatol (2011) 0.86

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. J Drugs Dermatol (2014) 0.86

Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol (2008) 0.85

The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis (2007) 0.85

Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction. Cutis (2009) 0.85

Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis. J Clin Aesthet Dermatol (2011) 0.85

Solitary sclerotic fibroma. J Clin Aesthet Dermatol (2009) 0.84

Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne. J Drugs Dermatol (2008) 0.84

Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol (2013) 0.84

Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation. J Drugs Dermatol (2009) 0.83

Healthcare utilization and costs of patients with rosacea in an insured population. J Drugs Dermatol (2008) 0.83

Comprehensive medical management of rosacea: an interim study report and literature review. J Clin Aesthet Dermatol (2008) 0.83

Pediatric Contact Dermatitis Registry Inaugural Case Data. Dermatitis (2016) 0.82

Skin cancer in asians: part 1: nonmelanoma skin cancer. J Clin Aesthet Dermatol (2009) 0.81

Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light. J Clin Aesthet Dermatol (2012) 0.80

Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options. Cutis (2006) 0.80

Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%). J Clin Aesthet Dermatol (2010) 0.80

Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses. J Clin Aesthet Dermatol (2009) 0.79

Tinea capitis in infants: recognition, evaluation, and management suggestions. J Clin Aesthet Dermatol (2012) 0.79

Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. J Clin Aesthet Dermatol (2013) 0.79

A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. Cutis (2009) 0.79

Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol (2011) 0.79

Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. Dermatol Online J (2007) 0.79

Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy. Dermatol Clin (2007) 0.78

Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects. J Drugs Dermatol (2008) 0.78

A review of delivery systems in cosmetics. Dermatol Ther (2012) 0.78

Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol (2011) 0.78

Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris. Cutis (2007) 0.78

Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. J Clin Aesthet Dermatol (2011) 0.78

Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications. J Drugs Dermatol (2016) 0.77

Evolving perspectives on the etiology and pathogenesis of acne vulgaris. J Drugs Dermatol (2015) 0.77

Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris. J Drugs Dermatol (2011) 0.77

Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach. J Clin Aesthet Dermatol (2010) 0.77

Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs Dermatol (2013) 0.77

Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen. J Drugs Dermatol (2010) 0.77

Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study. J Dermatolog Treat (2006) 0.77

Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape. J Drugs Dermatol (2015) 0.77

Optimal management of papulopustular rosacea: rationale for combination therapy. J Drugs Dermatol (2012) 0.76

The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician? J Drugs Dermatol (2013) 0.76

Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol (2014) 0.76

A status report on drug-associated acne and acneiform eruptions. J Drugs Dermatol (2010) 0.75

Avoiding the legal "blemish": medicolegal pitfalls in dermatology. J Clin Aesthet Dermatol (2009) 0.75

Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. J Clin Aesthet Dermatol (2009) 0.75

Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications. J Clin Aesthet Dermatol (2010) 0.75

Primary carcinosarcoma of the ear: case report and review of the literature. J Clin Aesthet Dermatol (2009) 0.75

Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study. J Clin Aesthet Dermatol (2008) 0.75

Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review. J Clin Aesthet Dermatol (2009) 0.75

Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol (2010) 0.75

Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin. J Clin Aesthet Dermatol (2013) 0.75

The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris. J Drugs Dermatol (2017) 0.75

Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery. J Drugs Dermatol (2010) 0.75

Management of Acne & Rosacea: Working Toward the Same Goals…Facing New Challenges. J Drugs Dermatol (2015) 0.75

Hyperkeratotic papular eruptions on legs, arms, and back. Int J Dermatol (2010) 0.75

Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J Drugs Dermatol (2013) 0.75

Acne and rosacea. J Drugs Dermatol (2008) 0.75

Message from the guest editor. J Drugs Dermatol (2012) 0.75

Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease? J Drugs Dermatol (2017) 0.75

The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach. J Drugs Dermatol (2012) 0.75

Topical tazarotene in acne vulgaris: treatment approaches. Cutis (2004) 0.75

A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium. J Drugs Dermatol (2013) 0.75

Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid. J Drugs Dermatol (2014) 0.75

The changing face of challenges in the management of acne and rosacea. J Drugs Dermatol (2014) 0.75

Laser and light-based therapies for acne vulgaris: a current guide based on available data. J Drugs Dermatol (2010) 0.75

A Consensus About the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants. J Drugs Dermatol (2020) 0.75

Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction. J Drugs Dermatol (2008) 0.75

Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it. J Drugs Dermatol (2011) 0.75

What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. J Drugs Dermatol (2013) 0.75

The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol (2012) 0.75

We are making progress with both acne and rosacea--but, let's face it! We still have a long way to go. J Drugs Dermatol (2010) 0.75

Overstating Conclusions from Population-Based Data: Be Careful What You Wish For! J Drugs Dermatol (2016) 0.75

Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. J Drugs Dermatol (2013) 0.75